Combination therapy with interferon-alpha-2b and hydroxyurea in patients with chronic myelogenous leukemia

By Hatzimichael E.C.   Bourantas K.L.  

European Journal of Internal Medicine, Vol. 10, Iss. 1, 1999-05 ,pp. : 27-31

Elsevier

Access to resources Recommend Favorite

Familial adenomatous polyposis complicated by chronic myelogenous leukemia: response to imatinib mesylate

By Itsukuma Takeyoshi   Ishikawa Hideki   Misawa Mahito   Kai Shunro   Fujimori Yoshihiro   Nakagawa Kazuhiko   Hirota Seiichi   Sugihara Ayako   Terada Nobuyuki   Hara Hiroshi  

Journal of Gastroenterology, Vol. 42, Iss. 5, 2007-05 ,pp. : 402-405

Springer Publishing Company

Access to resources Recommend Favorite

Rhabdomyolysis Associated with Fenofibrate Monotherapy in a Patient with Chronic Myelogenous Leukemia

By  

Case Reports in Gastroenterology, Vol. 5, Iss. 2, 2011-08 ,pp. : 492-496

Karger

Access to resources Recommend Favorite

Direct Medical Care Costs Among Pegylated Interferon Plus Ribavirin-Treated and Untreated Chronic Hepatitis C Patients

By Solomon M.  

Digestive Diseases and Sciences, Vol. 56, Iss. 10, 2011-10 ,pp. : 3024-3031

Springer Publishing Company

Access to resources Recommend Favorite

The expression kinetics of CD137 in chronic hepatitis C patients treated with pegylated-interferon and ribavirin

By Lee Sang Jin   Shin Jung Woo   Park Bo Ryung   Kim Chang Jae   Jung Seok Won   Kim Byunggyu   Jeong In Du   Bang Sung-Jo   Park Neung Hwa  

Scandinavian Journal of Gastroenterology, Vol. 47, Iss. 5, 2012-05 ,pp. : 601-606

Informa Healthcare

Access to resources Recommend Favorite